IDXX – IDEXX Laboratories, Inc.

IDXX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.65

Margin Of Safety %

-1

Put/Call OI Ratio

0.58

EPS Next Q Diff

0.31

EPS Last/This Y

1.44

EPS This/Next Y

1.89

Price

533.99

Target Price

727.54

Analyst Recom

Performance Q

-17.42

Upside

-44.0%

Beta

1.56

Ticker: IDXX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	IDXX	573.96	0.72	3.40	2906
2026-04-14	IDXX	583.67	0.73	0.71	2948
2026-04-15	IDXX	580.71	0.73	1.79	2957
2026-04-17	IDXX	589.56	0.71	0.57	2938
2026-04-20	IDXX	582.96	0.66	0.67	1662
2026-04-21	IDXX	569.03	0.65	0.42	1688
2026-04-23	IDXX	560.38	0.65	2.49	1717
2026-04-24	IDXX	565.92	0.66	0.55	1765
2026-04-27	IDXX	575.27	0.66	0.65	1765
2026-04-28	IDXX	568.24	0.65	0.30	1787
2026-04-29	IDXX	554.26	0.65	0.38	1804
2026-04-30	IDXX	560.92	0.64	4.18	1814
2026-05-01	IDXX	567.27	0.65	5.38	1830
2026-05-04	IDXX	562.83	0.70	0.96	1915
2026-05-05	IDXX	562.38	0.68	0.64	2030
2026-05-06	IDXX	579.22	0.63	0.42	2139
2026-05-07	IDXX	572.32	0.61	0.65	2155
2026-05-08	IDXX	559.85	0.61	1.16	2164
2026-05-11	IDXX	531.94	0.60	0.37	2161
2026-05-12	IDXX	533.99	0.58	0.25	2167
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	IDXX	574.21	15.4	128.5	14.51
2026-04-14	IDXX	584.05	15.4	125.1	14.52
2026-04-15	IDXX	580.47	15.4	91.1	14.52
2026-04-16	IDXX	570.09	15.4	73.5	14.52
2026-04-17	IDXX	589.76	15.4	149.9	14.52
2026-04-20	IDXX	583.23	15.3	85.2	14.51
2026-04-21	IDXX	569.06	15.3	65.4	14.51
2026-04-22	IDXX	578.32	15.3	123.4	14.51
2026-04-23	IDXX	560.86	15.3	56.4	14.51
2026-04-24	IDXX	566.03	15.3	113.0	14.51
2026-04-27	IDXX	575.05	15.3	123.1	14.51
2026-04-28	IDXX	568.43	15.3	83.6	14.51
2026-04-30	IDXX	560.79	15.2	118.4	14.51
2026-05-01	IDXX	567.76	15.2	117.8	14.51
2026-05-04	IDXX	562.50	15.2	87.4	14.51
2026-05-05	IDXX	562.38	15.2	98.0	14.51
2026-05-06	IDXX	579.58	15.2	143.9	14.51
2026-05-07	IDXX	572.55	8.1	-1.9	14.54
2026-05-08	IDXX	559.91	8.1	3.3	14.54
2026-05-11	IDXX	531.98	8.5	1.5	14.61
2026-05-12	IDXX	533.99	8.5	79.9	14.61
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	IDXX	-5.91	-0.31	2.43
2026-04-14	IDXX	-5.91	-0.31	2.43
2026-04-15	IDXX	-5.91	-0.31	2.43
2026-04-16	IDXX	-5.91	-0.31	2.43
2026-04-17	IDXX	-5.91	-0.31	2.43
2026-04-20	IDXX	-5.91	-0.55	2.43
2026-04-21	IDXX	-5.91	-0.55	2.43
2026-04-22	IDXX	-5.91	-0.55	2.41
2026-04-23	IDXX	-15.86	-0.55	2.41
2026-04-24	IDXX	-15.86	-0.55	2.41
2026-04-27	IDXX	-15.86	-0.30	2.61
2026-04-28	IDXX	-15.86	-0.30	2.61
2026-04-29	IDXX	-15.86	-0.30	2.61
2026-04-30	IDXX	-15.86	-0.30	2.61
2026-05-01	IDXX	-15.86	-0.30	2.61
2026-05-04	IDXX	-15.86	-0.31	2.61
2026-05-05	IDXX	-15.86	-0.31	2.61
2026-05-06	IDXX	-15.86	-0.31	2.61
2026-05-07	IDXX	-15.86	-0.31	2.61
2026-05-08	IDXX	-15.95	-0.31	2.63
2026-05-11	IDXX	-13.60	-0.21	2.63
2026-05-12	IDXX	-13.60	-0.21	2.65
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

3.47

Avg. EPS Est. Current Quarter

3.94

Avg. EPS Est. Next Quarter

3.78

Insider Transactions

-13.6

Institutional Transactions

-0.21

Beta

1.56

Average Sales Estimate Current Quarter

1199

Average Sales Estimate Next Quarter

1190

Fair Value

530.52

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

30.7

Max Drawdown 5-Year %

-54

Target Price

727.54

P/E

39.28

Forward P/E

32.3

PEG

2.55

P/S

9.47

P/B

27.19

P/Free Cash Flow

39.01

EPS

13.59

Average EPS Est. Cur. Y

14.61

EPS Next Y. (Est.)

16.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

24.63

Relative Volume

1.25

Return on Equity vs Sector %

43.5

Return on Equity vs Industry %

59.1

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.09

EBIT Estimation

79.9

◆ IDXX Healthcare

$533.92

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

19/25

Volume

1/15

Valuation

15/20

TP/AR

1/10

Options

5/10

RSI

36.8

Range 1M

18.3%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

16/30

Estimates

6/20

Inst/Vol

3/15

Options

9/10

EPS Yr

11.9%

EPS NY

13%

52W%

14.9%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🔴 SELL -8.9% upside

Quality

30/30

Valuation

1/30

Growth

15/25

Stability

5/10

LT Trend

4/5

Upside

-8.9%

Quality

MoS

-1%

IDEXX Laboratories, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 11000

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX

Latest News

—

Caricamento notizie per IDXX…

stock quote shares IDXX – IDEXX Laboratories, Inc. Stock Price stock today

news today IDXX – IDEXX Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IDXX – IDEXX Laboratories, Inc. yahoo finance google finance

stock history IDXX – IDEXX Laboratories, Inc. invest stock market

stock prices IDXX premarket after hours

ticker IDXX fair value insiders trading

IDXX – IDEXX Laboratories, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IDXX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y